A Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary Arterial Hypertension (PAH) Patients

Enrolling by invitationOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

June 30, 2030

Study Completion Date

June 30, 2030

Conditions
Pulmonary Arterial Hypertension
Trial Locations (18)

Unknown

Ordensklinikum Linz, Linz

Medical University Vienna, Vienna

Fakultní Nemocnice Olomouc, Olomouc

Všeobecná fakultní nemocnice v Praze, Prague

Hôpital Bicêtre-- Assistance Publique Hopitaux de Paris, Paris

Hôpitaux Universitaires de Strasbourg, Strasbourg

DRK Kliniken Berlin Westend, Berlin

University Hospital Carl Gustav Carus of Technical University Dresden, Dresden

Universitätsmedizin Greifswald, Greifswald

Gottsegen National Cardiovascular lnstitute, Budapest

Medical University of Szeged, Szeged

Sapienza University of Rome, Rome

John Paul II Hospital Krakow, Krakow

Fryderyk Chopin Hospital in European Health Centre Otwock, Otwock

Emergency Institute for Cardiovascular Diseases Prof. Dr. C.C.Iliescu, Bucharest

Emergency Clinical County Hospital of Targu Mures, Târgu Mureş

Hospital Clinic of Barcelona, Barcelona

Hospital Ramon y Cajal, Madrid

Sponsors
All Listed Sponsors
lead

AOP Orphan Pharmaceuticals AG

INDUSTRY

NCT06445673 - A Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary Arterial Hypertension (PAH) Patients | Biotech Hunter | Biotech Hunter